| Literature DB >> 36199313 |
Zexian Xu1,2, Yali Li1, Dian Xu1,2, Li Li1,2, Yaoxiang Xu1,2,3, Liqiang Chen1,2, Yanshan Liu1,2,3,4, Jian Sun1,2,3,4.
Abstract
Nano-hydroxyapatite (nHA) is widely used as a bio-scaffold material due to its good bioactivity and biocompatibility. In this study, fluorinated graphene oxide (FG) was added to nHA to improve its poor formability, weak mechanical properties, undesirable antimicrobial activity and other disadvantages that affect its clinical application. FG was synthesized by a simple hydrothermal method. Novel porous composite scaffolds were prepared by adding different weight ratios (0.1 wt%, 0.5 wt% and 1 wt%) of FG to nHA using the 3D printing technique. The morphology, phase composition and mechanical properties of the composite scaffolds were characterized. In addition, the degradation performance of the composite scaffolds, antibacterial activity against Staphylococcus aureus and Escherichia coli, and cytocompatibility were also investigated. The results showed that the nHA/FG composite scaffold was successfully prepared with a uniform distribution of FG on the scaffold. The mechanical properties showed that the compression strength of the nHA/FG composite scaffold was significantly higher than that of the nHA scaffold (7.22 ± 1.43 MPa). The porosity of all composite scaffolds was above 70%. The addition of FG significantly improved the mechanical properties of the nHA scaffold without affecting the porosity of the scaffold. In addition, the 0.5 wt% nHA/FG scaffold exhibited satisfactory cytocompatibility and antibacterial properties. Therefore, the constructed nHA/FG composite scaffold can be considered as a novel antimicrobial bone substitute material with good application prospects. This journal is © The Royal Society of Chemistry.Entities:
Year: 2022 PMID: 36199313 PMCID: PMC9450491 DOI: 10.1039/d2ra03854d
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1Characterization of FG: (a) TEM image, (b) size distribution, (c) AFM topography, (d) XPS survey spectrum, (e) C 1s XPS spectrum, (f) F 1s XPS spectrum, (g) XRD pattern, (h) Raman spectrum and (i) FTIR spectrum.
Fig. 2SEM images of the composite scaffolds at different magnifications.
Fig. 3Elemental analysis and distribution of composite scaffolds.
Fig. 4Characterization of nHA and nHA/FG composite scaffolds: (a) survey XPS spectra, (b) XRD pattern, (c) Raman spectrum and (d) FTIR spectrum.
Fig. 5The mechanical properties of nHA and nHA/FG composite scaffolds: (a) the contact angle, (b) the porosity and (c) the compressive strength.
Fig. 6(a) The degradation, (b) the cumulative release of Ca ions, (c) the cumulative release of P ions and (d) the cumulative release of F ions of nHA and nHA/FG composite scaffolds.
Fig. 7(a) Fluorescence microscopy images of FDA/PI staining, (b) CCK-8 assay results for MC3T3-E1 cells on composite scaffolds and (c) the hemolysis rate of composite scaffolds.
Fig. 8S. aureus and E. coli colonies on agar of blank control group, nHA (0 wt%), nHA/FG (0.1 wt%), nHA/FG (0.5 wt%) and nHA/FG (1 wt%).
Fig. 9Antibacterial rate of the composite scaffolds.